ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Transplant Hepatectomy with Portacaval Shunt and Molecular Adsorbent Recirculating System (MARS) Therapy for Perioperative Catastrophe

A. Cimeno, S. Sultan, J. Alvarez-Casas, S. Hanish, D. Bruno, W. Hutson, D. Stein, T. Scalea, R. Barth, J. LaMattina.

University of Maryland School of Medicine, Baltimore, MD.

Meeting: 2018 American Transplant Congress

Abstract number: A254

Keywords: Liver, Post-operative complications, Retransplantation, Surgical complications

Session Information

Date: Saturday, June 2, 2018

Session Name: Poster Session A: Liver Retransplantation and Other Complications

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Hall 4EF

Related Abstracts
  • Molecular Adsorbent Recirculating System (MARS) Effectively Replaces Hepatic Function in Severe Acute Liver Failure.
  • Children Listed as Status 1B for Liver Transplantation Are Disenfranchised by MARS Therapy.

Background: Increased worldwide focus on maximal donor utilization and transplantation of patients once considered too ill to survive liver transplantation may increase the otherwise rare frequency of catastrophic graft failure. Although the deleterious effects of a necrotic allograft have been established for decades, the optimal strategy in this patient population in the perioperative period remains ill-defined.

Methods: A retrospective review of all liver transplant recipients with massive post-operative liver necrosis leading to perioperative transplant hepatectomy between 1/1/2014 and 6/30/2017 was performed. All patients were supported with MARS therapy while awaiting retransplantation.

Results: Four patients experienced catastrophic graft failure from massive exsanguination and liver fracture (1), portal vein thrombosis (1), necrosis from inadequate donor perfusion (1), and idiopathic necrosis (1). All patients improved following transplant hepatectomy with portacaval shunting. Patients were supported with intubation, pressors, renal replacement therapy and MARS therapy. All patients underwent retransplantation after a mean anhepatic phase of 48.8 (+/- 5.13) hours. All patients were left with open abdomens following retransplantation, and required multiple procedures following the second transplant. Survival to discharge was 75%.

Conclusions: Although catastrophic liver necrosis presents innumerable challenges to the transplant team, acceptable outcomes can be achieved with timely hepatectomy with portacaval shunt and retransplantation, particularly in patients supported with the MARS device.

CITATION INFORMATION: Cimeno A., Sultan S., Alvarez-Casas J., Hanish S., Bruno D., Hutson W., Stein D., Scalea T., Barth R., LaMattina J. Transplant Hepatectomy with Portacaval Shunt and Molecular Adsorbent Recirculating System (MARS) Therapy for Perioperative Catastrophe Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Cimeno A, Sultan S, Alvarez-Casas J, Hanish S, Bruno D, Hutson W, Stein D, Scalea T, Barth R, LaMattina J. Transplant Hepatectomy with Portacaval Shunt and Molecular Adsorbent Recirculating System (MARS) Therapy for Perioperative Catastrophe [abstract]. https://atcmeetingabstracts.com/abstract/transplant-hepatectomy-with-portacaval-shunt-and-molecular-adsorbent-recirculating-system-mars-therapy-for-perioperative-catastrophe/. Accessed February 28, 2021.

« Back to 2018 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Left-Sided Donor Nephrectomy Predisposes Living Kidney Donors to Latent Adrenal Insufficiency with Symptoms of Fatigue and Inferior Quality of Life.
  • Home
  • Search
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.